2024

1. AI is a viable alternative to high throughput screening: a 318-target study

   Scientific Reports, Vol. 14, Núm. 1

2. An automated network-based tool to search for metabolic vulnerabilities in cancer

   Nature Communications , Vol. 15, Núm. 1

3. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

   Scientific Reports

4. Epigenetic-based differentiation therapy for Acute Myeloid Leukemia

   Nature Communications, Vol. 15, Núm. 1

5. G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1

   Cell Death and Disease, Vol. 15, Núm. 11

6. GeNNius: an ultrafast drug-target interaction inference method based on graph neural networks

   Bioinformatics (Oxford, England), Vol. 40, Núm. 1

7. HDACi vorinostat protects muscle from degeneration after acute rotator cuff injury in mice

   Bone and Joint Research, Vol. 12, Núm. 4, pp. 169-183

8. Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer

   Cell Death Discovery, Vol. 10, Núm. 1

9. Pharmacological inhibition of the integrated stress response accelerates disease progression in an amyotrophic lateral sclerosis mouse model

   British Journal of Pharmacology, Vol. 181, Núm. 3, pp. 495-508

10. Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment

    Archivos de Bronconeumologia, Vol. 60, pp. S67-S76

11. Study of pediatric invasive pneumococcal disease in the 13-pneumococcal conjugated vaccine era

    Diagnostic Microbiology and Infectious Disease, Vol. 110, Núm. 4